ADVISORY/Experts Available to Discuss New Guidelines for Heart Disease Prevention, Treatment in Women.

Business Editors

ADVISORY...

--(BUSINESS WIRE)

TOPIC: New guidelines for the prevention and treatment of heart disease in women were released by the American Heart Association Wednesday, according to an article by Reuters. The new guidelines are a culmination of information derived from more than 7,000 separate studies. Along with recommendations that women stop smoking, exercise daily and eat a healthy diet, the association suggested that women who are considered a high-risk for heart disease use drugs that lower cholesterol and blood pressure. High-risk women were defined as those who have diabetes, have had a heart attack or stroke, or already have heart disease. The American Heart Association claims 500,000 women in the United States die each year from heart disease.

EXPERTS: ExpertSource can offer several highly qualified experts to comment on this story:

Noel Bairey Merz, MD, a board certified specialist in Cardiovascular Diseases is the Women's Guild Endowed Chair in Health and the medical director of the Cedars-Sinai Women's Health Program. Dr. Bairey Merz is also the Director of the Preventative and Rehabilitative Cardiac Center at Cedars-Sinai Medical Center. Dr. Bairey Merz's expertise includes women and heart disease, mental stress and heart disease, the role of exercise and stress management in reversing disease, and the role of nutrition in heart disease. Currently, she is Chair of the NIH sponsored WISE (Women's Ischemic Syndrome Evaluation), a Co-Investigator in the NIH sponsored Vedic Medicine Efficacy studies and a Co-Investigator in the NIH sponsored Los Angeles Atherosclerosis Study, which is evaluating the role of antioxidants and pro-oxidants in cardiovascular disease. PR Contact: Michelle Wolf, 214-224-8418, [e-mail]

Seth Bilazarian, MD, has been a clinical and interventional cardiologist with Pentucket Medical Associates since 1993. Dr. Bilazarian performs coronary and peripheral interventions at Lahey Clinic. In the interventional laboratory, Dr. Bilazarian has been an investigator of new devices including drug eluting stents and distal protection devices. He is an active participant in clinical trials in congestive heart failure, hypertension and coronary disease prevention, including new lipid lowering therapies, pre-diabetes management and anticoagulation therapies in the outpatient setting. He is board certified in internal medicine, cardiovascular medicine, nuclear cardiology and interventional cardiology and is author of numerous papers and book chapters in clinical cardiology. 978-521-3288

Dr. Thomas Levin, of West Suburban Cardiologists, is an interventional cardiologist and expert in many aspects of heart disease particularly coronary artery disease and hemodynamics. He also has experience in valvular disease and its treatment. 708-952-7444, 773-702-1234 (University PR Phone)

ExpertSource cannot guarantee the immediate availability of these experts or their familiarity with this specific issue.

ExpertSource provides academic and industry experts to the media at no charge. Journalists are encouraged to submit queries to ExpertSource when seeking experts on specific subjects. An online registration form is available at http://www.businesswire.com/.